<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>3</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art20">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>71218</ArticleID>
            <ArticleDOI>10.1208/aapsj070120</ArticleDOI>
            <ArticleSequenceNumber>20</ArticleSequenceNumber>
            <ArticleTitle Language="En">Release and permeation kinetics of caffeine from bioadhesive transdermal films</ArticleTitle>
            <ArticleFirstPage>E218</ArticleFirstPage>
            <ArticleLastPage>E223</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>28</Day>
              </RegistrationDate>
              <Received>
                <Year>2004</Year>
                <Month>7</Month>
                <Day>27</Day>
              </Received>
              <Accepted>
                <Year>2004</Year>
                <Month>10</Month>
                <Day>12</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>1</IssueIDStart>
              <IssueIDEnd>1</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Sara</GivenName>
                  <FamilyName>Nicoli</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Paolo</GivenName>
                  <FamilyName>Colombo</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Patrizia</GivenName>
                  <FamilyName>Santi</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>+39 0521 905069</Phone>
                  <Fax>+39 0521905006</Fax>
                  <Email>patrizia.santi@unipr.it</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgName>Pharmacy Department</OrgName>
                <OrgAddress>
                  <Street>Parco Area delle Scienze 27/A</Street>
                  <Postcode>43100</Postcode>
                  <City>Parma</City>
                  <Country>Italy</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>The aim of this work was to investigate, in vitro, the kinetics of release and permeation of caffeine, chosen as model drug, from bioadhesive transdermal films. These films are not self-adhesive but become adhesive when applied to wet skin. Permeation experiments were performed from films with different drug loadings using rabbit ear skin as barrier. In order to characterize the release kinetics of caffeine from the film, a polyethylene membrane, impregnated with isopropyl myristate was employed. The data obtained in the present work suggest that caffeine release from transdermal bioadhesive films was controlled either by the permeability characteristics of the skin or by the film itself, depending on drug loading. When drug loading is low (ie, caffeine is dissolved in the polymers constituting the film), the control resides in the skin. When caffeine loading exceeds its solubility in the film, the permeation profile is not linear, but shows a sort of burst effect in the early times of permeation, probably owing to the presence of solid drug and/or to a certain degree of “conserved supersaturation” in the solid phase.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>transdermal</Keyword>
              <Keyword>caffeine</Keyword>
              <Keyword>permeation kinetics</Keyword>
              <Keyword>controlled release</Keyword>
              <Keyword>skin</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: September 2, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_71218.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Zhai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HI</Initials>
                    <FamilyName>Maibach</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Occlusion vs skin barrier function</ArticleTitle>
                  <JournalTitle>Skin Res Technol</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>6</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12005114</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.0909-752x.2001.10312.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhai H, Maibach HI. Occlusion vs skin barrier function.<Emphasis Type="Italic">Skin Res Technol</Emphasis>. 2002;8:1–6.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibUnstructured>Colombo P, Catellani PL, Padula C, Santi P, Colombo G. Film for Dermal and Transdermal Administration of Drugs. WO 02/30402. April 18, 2002.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Padula</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Colombo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Nicoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PL</Initials>
                    <FamilyName>Catellani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Massimo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Santi</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior</ArticleTitle>
                  <JournalTitle>J Control Release</JournalTitle>
                  <VolumeID>88</VolumeID>
                  <FirstPage>277</FirstPage>
                  <LastPage>285</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12628334</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-3659(03)00015-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhsFOltrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Padula C, Colombo G, Nicoli S, Catellani PL, Massimo G, Santi P. Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior.<Emphasis Type="Italic">J Control Release</Emphasis>. 2003;88:277–285.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Nicoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Amoretti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Colombo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Santi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Bioadhesive transdermal film containing caffeine</ArticleTitle>
                  <JournalTitle>Skin Pharmacol Appl Skin Physiol.</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>119</FirstPage>
                  <LastPage>123</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1159/000077237</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjtFKqsLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nicoli S, Amoretti V, Colombo P, Santi P. Bioadhesive transdermal film containing caffeine.<Emphasis Type="Italic">Skin Pharmacol Appl Skin Physiol.</Emphasis> 2004;17:119–123.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Amato</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Isenschmid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Huppi</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Percutaneous caffeine application in the treatment of neonatal apnea</ArticleTitle>
                  <JournalTitle>Eur J Pediatr</JournalTitle>
                  <VolumeID>150</VolumeID>
                  <FirstPage>592</FirstPage>
                  <LastPage>594</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1954966</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF02072214</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK38%2Fmtl2lug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Amato M, Isenschmid M, Huppi P. Percutaneous caffeine application in the treatment of neonatal apnea.<Emphasis Type="Italic">Eur J Pediatr</Emphasis>. 1991;150:592–594.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Conney</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YP</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YR</Initials>
                    <FamilyName>Lou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MT</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Inhibitory effects of tea and caffeine on UV-induced carcinogenesis: relationship to enhanced apoptosis and decreased tissue fat</ArticleTitle>
                  <JournalTitle>Eur J Cancer Prev</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>S28</FirstPage>
                  <LastPage>S36</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12570332</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Conney AH, Lu YP, Lou YR, Huang MT. Inhibitory effects of tea and caffeine on UV-induced carcinogenesis: relationship to enhanced apoptosis and decreased tissue fat.<Emphasis Type="Italic">Eur J Cancer Prev</Emphasis>. 2002;11:S28-S36.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Bertin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Zunino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JC</Initials>
                    <FamilyName>Pitter</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">A double-blind evaluation of the activity of an anti-cellulite product containing retinol, caffeine, and ruscogenine by a combination of several non-invasive methods</ArticleTitle>
                  <JournalTitle>J Cosmet Sci</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>199</FirstPage>
                  <LastPage>210</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11479653</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xps1Knsb4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bertin C, Zunino H, Pitter JC, et al., A double-blind evaluation of the activity of an anti-cellulite product containing retinol, caffeine, and ruscogenine by a combination of several non-invasive methods.<Emphasis Type="Italic">J Cosmet Sci</Emphasis>. 2001;52:199–210.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HG</Initials>
                    <FamilyName>Mandel</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Update on caffeine consumption, disposition and action</ArticleTitle>
                  <JournalTitle>Food Chem Toxicol</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>1231</FirstPage>
                  <LastPage>1234</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12204386</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0278-6915(02)00093-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XmsVers7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mandel HG. Update on caffeine consumption, disposition and action.<Emphasis Type="Italic">Food Chem Toxicol</Emphasis>. 2002;40:1231–1234.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BJ</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TR</Initials>
                    <FamilyName>Gunn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NH</Initials>
                    <FamilyName>Holford</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Caffeine overdose in a premature infant: clinical course and pharmacokinetics</ArticleTitle>
                  <JournalTitle>Anaesth Intensive Care</JournalTitle>
                  <VolumeID>27</VolumeID>
                  <FirstPage>307</FirstPage>
                  <LastPage>311</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10389569</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1Mzhslyjsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Anderson BJ, Gunn TR, Holford NH, Johnson R. Caffeine overdose in a premature infant: clinical course and pharmacokinetics.<Emphasis Type="Italic">Anaesth Intensive Care</Emphasis>. 1999;27:307–311.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Monti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Giannelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Chetoni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Burgalassi</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Comparison of the effect of ultrasound and of chemical enhancers on transdermal permeations of caffeine and morphine through hairless mouse skin in vitro</ArticleTitle>
                  <JournalTitle>Int J Pharm</JournalTitle>
                  <VolumeID>229</VolumeID>
                  <FirstPage>131</FirstPage>
                  <LastPage>137</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11604265</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0378-5173(01)00830-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXntlKnsbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Monti D, Giannelli R, Chetoni P, Burgalassi S. Comparison of the effect of ultrasound and of chemical enhancers on transdermal permeations of caffeine and morphine through hairless mouse skin in vitro.<Emphasis Type="Italic">Int J Pharm</Emphasis>. 2001:229:131–137.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dias</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Farinha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Faustino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Hadgraft</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Pais</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Toscano</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Topical delivery of caffeine from some commercial formulations</ArticleTitle>
                  <JournalTitle>Int J Pharm</JournalTitle>
                  <VolumeID>182</VolumeID>
                  <FirstPage>41</FirstPage>
                  <LastPage>47</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10332073</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0378-5173(99)00067-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXjtVyksro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dias M, Farinha A, Faustino E, Hadgraft J, Pais J, Toscano C. Topical delivery of caffeine from some commercial formulations.<Emphasis Type="Italic">Int J Pharm</Emphasis>. 1999;182:41–47.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
